top of page
Compliance in the Digital Age: Navigating Enforcement, Marketing Risks, and the Rise of AI | State of the Supplement Industry
Asa Waldstein
Guest Article
Emerging enforcement trends include FDA focus on documentation and identity testing, and increased scrutiny of online claims
Although the pace of FDA warning letters to dietary supplement companies appears to have slowed over the past 12 months, several important enforcement themes continue.
GMP compliance remains a central focus, particularly regarding incomplete identity and finished product composition testing. The FDA’s long-standing mantra still applies: If it’s not written down, it didn’t happen.
bottom of page



